Clinical Trial Update: Autologous Vaccination With Lethally Irradiated, Autologous Breast Cancer Cells Engineered to Secrete GM-CSF in Women With Operable Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating autologous GM-CSF-secreting cancer cell vaccine for operable breast cancer has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Autologous Lethally Irradiated Breast Cancer Cells Engineered to Secrete GM-CSF

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Breast Cancer | Phase 1 | Status: COMPLETED | Results posted: 2021-11-09